Total Results: 11414
Media outlets report on news from Ohio, Iowa, Tennessee, Pennsylvania, California, Oregon, Louisiana, Maryland and Virginia.
However, while many states are focusing on pharmaceutical companies alone, New Mexico is also going after distributors. Media outlets report on news about the epidemic out of Arizona, Florida and Ohio, as well.
“Our goal is to ensure that consumers have adequate time to shop for and enroll in the health plan that is best for their family,” Donna Frescatore, executive director of New York State of Health, says. In other news, Covered California announces premium increases for its small-business exchange.
Despite support from President Donald Trump, the bill by Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) isn’t getting a warm welcome from colleagues on the Hill.
The governors, both Republicans and Democrats, weighed in on their thoughts about how to stabilize the marketplace at a hearing in front of the Senate Health, Education, Labor and Pensions Committee. But when they brought up reinsurance, Chairman Lamar Alexander shot them down.
State leaders tell senators that federal dollars are needed this fall to keep insurers participating in Obamacare next year and prevent big hikes in premiums.
The federal health law includes a provision that allows states to alter some of its rules if they can think of a better way to provide health care to their residents, but it’s not clear how far outside the box states can go.
A selection of opinions on health care from around the country.
Media outlets report on news from Massachusetts, Pennsylvania, Georgia, Connecticut, Wisconsin and Minnesota.
Also in the news, lobbyists double down on efforts surrounding a California prescription drug pricing transparency bill.
The fate of the clinic will be decided by a federal trial that kicked off on Wednesday.
Sens. Elizabeth Warren (D-Mass.) and Shelley Moore Capito (R-W.Va.) say the clause would let patients decide if they wanted less than the full prescription in their homes. In other news, the Food and Drug Administration issues a warning to a drugmaker for its marketing tactics, a task force releases recommendations on fighting the epidemic, a new study finds addiction medication has little impact on users, and more.
Organizations such as Protect Our Care and health care leaders like Andy Slavitt, former acting administrator of the Centers for Medicare & Medicaid Services, are trying to keep the momentum going to get people to enroll in health care coverage for next year. Media outlets report on marketplace news out of Virginia, Kentucky, Colorado and Ohio, as well.
Making needed fixes to Obamacare before next year may be more difficult — and expensive — than Senate leaders think, state insurance commissioners suggested at a Senate hearing Wednesday.
Media outlets report on news from Utah, Kentucky, Massachusetts, New York, Georgia, Minnesota, Colorado, New Hampshire, Wisconsin, Ohio and Tennessee.
The person that takes current director Mikki Stier’s position will have a lot to do because of Iowa’s controversial shift to private management of Medicaid. Meanwhile in Oregon, lawmakers hold a hearing on a tax that would close a hole in the state’s Medicaid budget.
Those who are victims of such an attack often don’t report it out of shame, distrust of police or fear they’ll be labeled a “cop caller” and have trouble buying heroin. In other news: the opioid epidemic view through an economic lens; states worry that a federal logjam is hampering efforts to fight the crisis; and more.
These officials are tasked with the unenviable job of keeping the markets stable as uncertainty reigns supreme. Meanwhile, a look at one who’s made national headlines for her candid take on the state of the exchanges.
Republicans are now in the position to have to work with Democrats so make sure the marketplace doesn’t collapse. The Senate Health, Education, Labor and Pensions Committee is holding four hearings to kick off those efforts. Meanwhile, President Donald Trump isn’t ready to give up on repeal just yet.
The fate of the Affordable Care Act’s individual insurance marketplaces remains in play as state insurance commissioners take a central role in the debate.